Should a 50-year-old cancer patient join a clinical trial?

Question

Hello doctor,

My father, 50, has been diagnosed with advanced lung cancer, and his doctor mentioned the option of enrolling in a clinical trial. This has made us curious and a bit unsure about whether a 50-year-old cancer patient should join a clinical trial. We understand that trials can offer new treatments, but we are also worried about risks and uncertain outcomes.

How do we evaluate if a clinical trial is the right choice compared to standard treatment?
Are there specific factors we should consider before making this decision?

We just want to make an informed choice.

Kindly help.

Answer 1

Hello,

Welcome to icliniq.com.

I understand your concern.

I wish you and your father good health and a speedy recovery for your father. First of all, we choose when to go for clinical trials. Clinical trials provide medications that we consider safe for the patient and, at the same time, are usually expensive. That is why we prefer to use clinical trials.

Cancer treatment includes chemotherapy, which is the traditional treatment. In older patients, chemotherapy has many side effects because it affects all body systems, so we do not usually prefer chemotherapy for elderly patients. We prefer to give them targeted therapy or immunotherapy.

Immunotherapy medications are very important. Their side effects are minimal, and the patient can live well with them. In many cases, we have seen patients live more than ten years on immunotherapy without any significant side effects. Therefore, we prefer to give immunotherapy or targeted therapy.

Regarding tests to determine which treatment to give, we perform genomic testing, which is also expensive, and the treatment itself is expensive. That is why we prefer to use clinical trials. The results are usually very good, and patients are very satisfied with their treatment and management.

I hope you are satisfied with my answer. For further queries, you can consult me at iCliniq.

Thank you.